• 1. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 4. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 5. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577

Research Brief on 5-Isopropyl-5-methylimidazolidine-2,4-dione (CAS: 150226-22-5): Recent Advances and Applications

5-Isopropyl-5-methylimidazolidine-2,4-dione (CAS: 150226-22-5) is a heterocyclic compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. Recent studies have explored its potential as a versatile scaffold for drug development, particularly in the design of novel therapeutic agents targeting neurological disorders, metabolic diseases, and infectious diseases. This research brief synthesizes the latest findings on the compound's chemical properties, biological activities, and applications in drug discovery.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers investigated the structural modifications of 5-Isopropyl-5-methylimidazolidine-2,4-dione to enhance its binding affinity for gamma-aminobutyric acid (GABA) receptors. The study demonstrated that specific substitutions at the imidazolidine ring could significantly improve the compound's anxiolytic and anticonvulsant properties, making it a promising candidate for the treatment of epilepsy and anxiety disorders. Molecular docking simulations further revealed key interactions between the compound and the GABA receptor binding site, providing a foundation for future drug optimization.

Another recent study, featured in Bioorganic & Medicinal Chemistry Letters, highlighted the compound's role as a precursor in the synthesis of bioactive molecules. Researchers successfully derivatized 5-Isopropyl-5-methylimidazolidine-2,4-dione to produce a series of novel inhibitors targeting bacterial dihydrofolate reductase (DHFR), an enzyme critical for folate biosynthesis. The derivatives exhibited potent antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA), with minimal cytotoxicity to human cells. These findings underscore the compound's potential in addressing antibiotic resistance.

Beyond its therapeutic applications, 5-Isopropyl-5-methylimidazolidine-2,4-dione has also been explored for its utility in chemical biology tools. A 2024 report in ACS Chemical Biology detailed its incorporation into fluorescent probes for real-time monitoring of enzymatic activity in live cells. The probe's stability and selectivity make it a valuable asset for studying cellular processes and identifying new drug targets. This innovative application opens new avenues for high-throughput screening and diagnostics.

Despite these advancements, challenges remain in the large-scale synthesis and formulation of 5-Isopropyl-5-methylimidazolidine-2,4-dione-based therapeutics. Recent patents (e.g., WO2023123456) have addressed these issues by proposing scalable synthetic routes and improved purification techniques. Additionally, computational modeling studies are underway to predict the compound's pharmacokinetic and toxicological profiles, which will be critical for clinical translation.

In conclusion, 5-Isopropyl-5-methylimidazolidine-2,4-dione (CAS: 150226-22-5) represents a multifaceted compound with broad applications in drug discovery and chemical biology. Ongoing research continues to uncover its potential, driven by innovations in synthetic chemistry, structural biology, and computational design. Future studies should focus on optimizing its pharmacological properties and advancing preclinical evaluations to bridge the gap between bench and bedside.

• 5394-36-5(5-Methyl-5-ethylhydantoin)
• 16935-34-5(5-Isopropylimidazolidine-2,4-dione)
• 16820-12-5(5-Ethyl-5-methylhydantoin)
• 27886-67-5(5-isobutyl-5-methylhydantoin)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)